Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

Abstract

In this study, sitagliptin was generally well tolerated and provided effective glycaemic control in patients with type 2 diabetes and moderate to severe renal insufficiency, including patients with ESRD on dialysis.